Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is -23.55% vs 43.40% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 8.21% vs 147.99% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is -3.14% vs 192.10% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is 0.40% vs 0.00% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
Compare Quarterly Results Of Hybio Pharmaceutical Co.. Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is -23.55% vs 43.40% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 130.18% vs -29.23% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 8.21% vs 147.99% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 2,108.82% vs 106.39% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is -3.14% vs 192.10% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 685.71% vs 238.79% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 0.40% vs 0.00% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -6.30% vs -2.17% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






